However, TβR-I aberrant methylation was shown in early (I and II) and advanced (III and IV) tumor stages suggesting that epigenetic disruption of TGF-β signaling by aberrant methylation might contribute to the progression of HNSCCs. The gene discussed is TGFB1; the disease is neoplasm.